冠状病毒疾病威胁管理战略计划：推进一体化、可持续性和公平性，2025-2030

Advancing integration, sustainability, andequity, 2025–2030 Strategic plan for Advancing integration, sustainability, andequity, 2025–2030 Strategic plan for coronavirus disease threat management:Advancing integration, sustainability, and ISBN978-92-4-011766-2(electronic version) ISBN978-92-4-011767-9(print version) © World Health Organization 2025 Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0IGO licence (CCBY-NC-SA3.0IGO;https://creativecommons.org/licenses/by-nc- Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercialpurposes, provided the work is appropriately cited, as indicated below. In any use of this work, thereshould be no suggestion that WHO endorses any specificorganization, products or services. The use ofthe WHO logo is not permitted. If you adapt the work, then you must license your work under the sameor equivalent Creative Commons licence. If you create a translation of this work, you should add the Any mediation relating to disputes arising under the licence shall be conducted in accordance with themediation rules of the World Intellectual Property Organization (http://www.wipo.int/amc/en/ Suggested citation.Strategic plan for coronavirus disease threat management: advancing integration,sustainability, and equity, 2025–2030. Geneva: World Health Organization;2025. Licence:CCBY-NC- Sales, rights and licensing.To purchase WHO publications, see https://www.who.int/publications/book-orders. To submit requests for commercial use and queries on rights and licensing, seehttps://www.who.int/copyright. Third-party materials.If you wish to reuse material from this work that is attributed to a third party,such as tables, figures or images, it is your responsibility to determine whether permission is neededfor that reuse and to obtain permission from the copyright holder. Therisk of claims resulting from General disclaimers.The designations employed and the presentation of the material in thispublication do not imply the expression of any opinion whatsoever on the part of WHO concerning thelegal status of any country, territory, city or area or of its authorities, or concerning the delimitation of The mention of specific companies or of certain manufacturers’ products does not imply that they areendorsed or recommended by WHOin preference to others of a similar nature that are not mentioned. All reasonable precautions have been taken by WHOto verify the information contained in thispublication. However, the published material is being distributed without warranty of any kind, eitherexpressed or implied. The responsibility for the interpretation and use of the material lies with the Contents Foreword....................................................................................................................................vAcknowledgements......................................................................................................................viAbbreviations.............................................................................................................................viiAt a glance: Executive summary.....................................................................................................8Introduction................................................................................................................................1Context..................................................................................................................................................................1Purpose of this document....................................................................................................................................2Defining disease threat management............................................................................................................3Target audience....................................................................................................................................................4Scope....................................................................................................................................................................4Document structure.............................................................................................................................................4Strategic objectives......................................................................................................................6Leveraging lessons from COVID-19.................................................................................................................8Operationalizing the strategic objectives.......................................................................................10C1.Collaborative surveillance...........................................................................................................................11C2.Commu